The Lung Institute Offers Natural Treatment Options for Pulmonary Fibrosis

Natural treatment options for pulmonary fibrosis can include making lifestyle changes such as getting more exercise, maintaining a healthy diet and quitting smoking. At the Lung Institute, we are proud to offer an additional natural approach to treating pulmonary fibrosis – stem cell therapy. As the world’s only stem cell center that focuses exclusively on the treatment of lung conditions, we offer a unique opportunity to work with a dedicated medical team that truly specializes in pulmonary care through stem cell therapy.

We offer two different forms of stem cell therapy, each with the goal of reducing lung inflammation, improving lung function and potentially slowing the progression of pulmonary fibrosis. These forms include venous stem cell therapy (in which the stem cells are derived from the patient’s own blood) and bone marrow stem cell therapy (in which the stem cells are harvested from the patient’s bone marrow). During both of these minimally invasive procedures, our caring medical team will:

  • Draw the blood or bone marrow from the patient’s body
  • Separate the stem cells from the other cells in our onsite lab
  • Intravenously reintroduce the separated stem cells into the patient’s body to help stimulate the body’s natural healing processes

Because the stem cell therapy we perform is autologous, or coming from the patient’s own body, there is very little risk of rejection. Both treatments are performed on an outpatient basis over the course of two days, and most patients are able to return to their regular activities immediately following the procedure. While no treatment can reverse lung damage, regenerate tissue or cure lung disease, stem cell therapy can potentially slow the progression of the condition and improve the patient’s overall quality of life.

To learn more about how stem cell therapy can be used as a natural treatment option for pulmonary fibrosis, call the Lung Institute team today at (800) 729-3065.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.